Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action

Quayle, L.A., Pereira, M.G., Scheper, G. et al. (5 more authors) (2017) Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action. Oncotarget, 8 (51). pp. 88670-88688.

Abstract

Metadata

Authors/Creators:
  • Quayle, L.A.
  • Pereira, M.G.
  • Scheper, G.
  • Wiltshire, T.
  • Peake, R.E.
  • Hussain, I.
  • Rea, C.A.
  • Bates, T.E.
Copyright, Publisher and Additional Information: © Quayle et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: angiogenesis; chemotherapy; breast cancer; lung cancer; mitochondria
Dates:
  • Accepted: 17 June 2017
  • Published: 13 September 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 09 Jan 2018 13:08
Last Modified: 09 Jan 2018 13:08
Published Version: https://doi.org/10.18632/oncotarget.20858
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.20858
Related URLs:

Export

Statistics